Catalyst Wire Dossier Catalyst Wire Dossier

KPD regimen

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KPD regimen, covering 2025-02-19 to 2025-02-19. Get the full timeline:

Most recent: Clinical Trial Update: All-trans Retinoic Acid in Combination With a KPD Regimen for the Treatment of Refractory/Relapsed Multiple Myeloma [Phase 2]

See pricing